Bandingkan Harga & Kinerja Indofarma Tbk. (INAF) vs Tanah Laut Tbk (INDX)
Kinerja harga (24 Jam Terakhir)
Statistik utama
Statistik utama
Perbedaan Indofarma Tbk. dan Tanah Laut Tbk: Indofarma Tbk. diperdagangkan di Rp126 (kapitalisasi pasar 390,51 M), sedangkan Tanah Laut Tbk diperdagangkan di Rp60 (kapitalisasi pasar 26,27 M). Perbedaan utamanya: Indofarma Tbk. jauh lebih besar — sekitar 14,9× kapitalisasi pasar Tanah Laut Tbk. Mana yang lebih baik tergantung tujuan investasimu.
| INAF | INDX | |
|---|---|---|
Kapitalisasi Pasar | 390,51 M | 26,27 M |
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Berita terkini
Berita terbaru kedua aset
Berita terkini
Berita terbaru kedua aset
Tentang Indofarma Tbk.
PT Indonesia Farma Tbk, known as PT Indofarma (Persero) Tbk (the Company) was established based on Deed No. 1 dated January 2, 1996 as amended by Deed No. 134 dated January 26, 1996 both of Notary Sutjipto, SH. PT. Indofarma, Tbk began as medicine factory well known as "Pabrik Obat Manggarai". Then take over by Japan's Government from Nederland's Government on 1942. On 1950 the Indonesian Government acquisited the factory by Department of Health and functioned as center of pharmacy production for its department. On 1979 the name changed to be Department of Health Center of Pharmacy Production as non Profit institution as main assignment to produced medicine for public service. Then the Company changed the name as PT. Indonesia Farma Tbk, known as PT Indofarma (Persero) Tbk.
Selengkapnya di halaman INAF →Tentang Tanah Laut Tbk
PT Tanah Laut Tbk formerly PT Indoexchange Tbk (the Company) was established under the name PT Sanggrahamas Dipta based on Notarial Deed No.78 dated September 19, 1991 of Rahmah Arie Sutarjo, S.H., notary in Jakarta. The Company changed its status from Foreign Capital Investment Company to Domestic Capital Investment Company, approved by the Chairman of Capital Investment Coordinating Board in accordance with Approval Letter No. 38/V/PMDN/2008 dated September 23, 2008.
Selengkapnya di halaman INDX →
